Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Expression of p16(Ink4a) and p19(Arf) increases with age in both rodent and human tissues. However, whether these tumour suppressors are effectors of ageing remains unclear, mainly because knockout mice lacking p16(Ink4a) or p19(Arf) die early of tumours. Here, we show that skeletal muscle and fat, two tissues that develop early ageing-associated phenotypes in response to BubR1 insufficiency, have high levels of p16(Ink4a) and p19(Arf). Inactivation of p16(Ink4a) in BubR1-insufficient mice attenuates both cellular senescence and premature ageing in these tissues. Conversely, p19(Arf) inactivation exacerbates senescence and ageing in BubR1 mutant mice. Thus, we identify BubR1 insufficiency as a trigger for activation of the Cdkn2a locus in certain mouse tissues, and demonstrate that p16(Ink4a) is an effector and p19(Arf) an attenuator of senescence and ageing in these tissues.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with this idea is the observation that interference with senescent cell accumulation in BubR1 progeroid mice delays several aging-associated disorders that these animals develop 4 , 5 .”
From Naturally occurring p16Ink4a-positive cells shorten healthy lifespan (2016) · cites this paper as [5]
In the citing paper
“In the absence of p16, the age-related deterioration of adipose tissue, skeletal muscle and eye was attenuated193.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [193]
In the citing paper
“Importantly, genetically preventing the accumulation of p19ARF, a tumour suppressor that modulates the stability of p53 by influencing MDM2-mediated destruction, did not result in similar prevention193, indicating that p16 was critical for these disorders.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [193]
In the citing paper
“Removal of SnCs delays several pathologies7–9 and increases healthy lifespan8.”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [9]
In the citing paper
“Remarkably, treated mice of both BubR1H/H;INK-ATTAC lines had substantially delayed onset of lordokyphosis (a measure of sarcopenia onset in this model15) and cataracts compared to untreated mice (Fig. 2b, c).”
From Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders (2011) · cites this paper as [15]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708
Ink4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
Kondratov, R. V., Kondratova, A. A., Gorbacheva, V. Y., Vykhovanets, O. V., & Antoch, M. P. (2006) · Genes & Development · doi:10.1101/gad.1432206 · Cited by 1,188
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a
Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., Cheng, T., DePinho, R. A., Sharpless, N. E., & Scadden, D. T. (2006) · Nature · doi:10.1038/nature05159 · Cited by 1,106
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009 · cited 1×
“Both p16 Ink4a and p19 Arf are effectors of senescence in cultured cell”
Backgroundp16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003 · cited 1×
“Recent evidence in middle-aged p16 Ink4a knockout mice indicates that the age-induced expression of p16 Ink4a limits the proliferative and regenerative capacity of progenitor population”
BackgroundIncreasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing
Molofsky, A. V., Slutsky, S. G., Joseph, N. M., He, S., Pardal, R., Krishnamurthy, J., Sharpless, N. E., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature05091 · Cited by 972 · cited 1×
“Recent evidence in middle-aged p16 Ink4a knockout mice indicates that the age-induced expression of p16 Ink4a limits the proliferative and regenerative capacity of progenitor population”
BackgroundLoss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A. (2001) · Nature · doi:10.1038/35092592 · Cited by 848
Microarray analysis of replicative senescence
Shelton, D. N., Chang, E., Whittier, P. S., Choi, D., & Funk, W. D. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80420-5 · Cited by 764
How stem cells age and why this makes us grow old
Sharpless, N. E., & DePinho, R. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2241 · Cited by 743
BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice
Baker, D. J., Jeganathan, K. B., Cameron, J. D., Thompson, M., Juneja, S., Kopecka, A., Kumar, R., Jenkins, R. B., de Groen, P. C., Roche, P., et al. (2004) · Nature Genetics · doi:10.1038/ng1382 · Cited by 731
Self-citationAneuploidy Acts Both Oncogenically and as a Tumor Suppressor
Weaver, B. A. A., Silk, A. D., Montagna, C., Verdier-Pinard, P., & Cleveland, D. W. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.003 · Cited by 729
Rane, S. G., Dubus, P., Mettus, R. V., Galbreath, E. J., Boden, G., Reddy, E. P., & Barbacid, M. (1999) · Nature Genetics · doi:10.1038/8751 · Cited by 700
Sherr, C. J., & Weber, J. D. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00038-6 · Cited by 654
Rapid examination of muscle tissue: An improved trichrome method for fresh‐frozen biopsy sections
Engel, W. K., & Cunningham, G. G. (1963) · Neurology · doi:10.1212/wnl.13.11.919 · Cited by 582
Zindy, F., Quelle, D. E., Roussel, M. F., & Sherr, C. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201178 · Cited by 574
The INK4A/ARF locus and its two gene products.
Sharpless, N. E., & DePinho, R. A. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80004-5 · Cited by 533 · cited 1×
“The Cdkn2a locus encodes two separate tumour suppressors, p16 Ink4a , a cyclin-dependent kinase (Cdk) inhibitor that can block G 1 –S progression when present above a certain level, and p19 Arf , a positive regulator of the transcription factor p53 that integrates and responds to a wide variety of cellular stresse”
Beauchamp, J. R., Morgan, J. E., Pagel, C. N., & Partridge, T. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.6.1113 · Cited by 514
Delayed ageing through damage protection by the Arf/p53 pathway
Matheu, A., Maraver, A., Klatt, P., Flores, I., Garcia-Cao, I., Borras, C., Flores, J. M., Viña, J., Blasco, M. A., & Serrano, M. (2007) · Nature · doi:10.1038/nature05949 · Cited by 466
Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation
Varela, I., Cadiñanos, J., Pendás, A. M., Gutiérrez-Fernández, A., Folgueras, A. R., Sánchez, L. M., Zhou, Z., Rodríguez, F. J., Stewart, C. L., Vega, J. A., et al. (2005) · Nature · doi:10.1038/nature04019 · Cited by 466
Babu, J. R., Jeganathan, K. B., Baker, D. J., Wu, X., Kang-Decker, N., & van Deursen, J. M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211048 · Cited by 339
Self-citationKasper, L. H., Brindle, P. K., Schnabel, C. A., Pritchard, C. E. J., Cleary, M. L., & van Deursen, J. M. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.764 · Cited by 320
Breast tumor copy number aberration phenotypes and genomic instability
Fridlyand, J., Snijders, A. M., Ylstra, B., Li, H., Olshen, A., Segraves, R., Dairkee, S., Tokuyasu, T., Ljung, B. M., Jain, A. N., et al. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-96 · Cited by 298
Cao, L., Li, W., Kim, S., Brodie, S. G., & Deng, C.-X. (2003) · Genes & Development · doi:10.1101/gad.1050003 · Cited by 293
Increased Expression of Mitotic Checkpoint Genes in Breast Cancer Cells with Chromosomal Instability
Yuan, B., Xu, Y., Woo, J.-H., Wang, Y., Bae, Y. K., Yoon, D.-S., Wersto, R. P., Tully, E., Wilsbach, K., & Gabrielson, E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0903 · Cited by 273
p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a
Krimpenfort, P., IJpenberg, A., Song, J.-Y., van der Valk, M., Nawijn, M., Zevenhoven, J., & Berns, A. (2007) · Nature · doi:10.1038/nature06084 · Cited by 269
Maes, C., Stockmans, I., Moermans, K., Van Looveren, R., Smets, N., Carmeliet, P., Bouillon, R., & Carmeliet, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19383 · Cited by 266
Latres, E. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3496 · Cited by 257
West, M. D., Pereira-Smith, O. M., & Smith, J. R. (1989) · Experimental Cell Research · doi:10.1016/0014-4827(89)90372-8 · Cited by 241
Maes, C., Stockmans, I., Moermans, K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419383 · Cited by 233
The differential impact of p16INK4a or p19ARF deficiency on cell growth and tumorigenesis
Sharpless, N. E., Ramsey, M. R., Balasubramanian, P., Castrillon, D. H., & DePinho, R. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207074 · Cited by 224
Cataloging altered gene expression in young and senescent cells using enhanced differential display
Linskens, M. H. K., Feng, J., Andrews, W. H., Enlow, B. E., Saati, S. M., Tonkin, L. A., Funk, W. D., & Villeponteau, B. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.16.3244 · Cited by 223
Cancer and ageing: convergent and divergent mechanisms
Serrano, M., & Blasco, M. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2242 · Cited by 182 · cited 1×
“It has been proposed that the p19 Arf –p53 pathway in response to low, chronic stress, may primarily induce genes that promote cell survival and repair, thereby extending lifespa”
Early aging–associated phenotypes in Bub3/Rae1 haploinsufficient mice
Baker, D. J., Jeganathan, K. B., Malureanu, L., Perez-Terzic, C., Terzic, A., & van Deursen, J. M. A. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200507081 · Cited by 175
Self-citationGene expression profiling of aging reveals activation of a p53-mediated transcriptional program
Edwards, M. G., Anderson, R. M., Yuan, M., Kendziorski, C. M., Weindruch, R., & Prolla, T. A. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-80 · Cited by 174
Protective Effects of Statins Involving Both eNOS and tPA in Focal Cerebral Ischemia
Asahi, M., Huang, Z., Thomas, S. S., Yoshimura, S., Sumii, T., Mori, T., Qiu, J., Amin‐Hanjani, S., Huang, P. L., Liao, J. K., et al. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600070 · Cited by 157
Balancing regeneration and cancer
Beausejour, C. M., & Campisi, J. (2006) · Nature · doi:10.1038/nature05221 · Cited by 145
Kane, G. C., Behfar, A., Yamada, S., Pérez-Terzic, C. M., O’Cochlain, F., Reyes, S., Dzeja, P. P., Miki, T., Seino, S., & Terzic, A. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s169 · Cited by 109
Self-citationYamada, S., Kane, G. C., Behfar, A., Liu, X., Dyer, R. B., Faustino, R. S., Miki, T., Seino, S., & Terzic, A. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.119511 · Cited by 107
Self-citationJeong, Y. J., Choi, H., Shin, H., Cui, X., Kim, N., Gerton, G. L., & Jun, J. H. (2005) · Molecular Reproduction and Development · doi:10.1002/mrd.20269 · Cited by 99
Aging-Associated Vascular Phenotype in Mutant Mice With Low Levels of BubR1
Matsumoto, T., Baker, D. J., d’Uscio, L. V., Mozammel, G., Katusic, Z. S., & van Deursen, J. M. (2007) · Stroke · doi:10.1161/01.str.0000257967.86132.01 · Cited by 77
Self-citationMice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration
Koh, T. J., Bryer, S. C., Pucci, A. M., & Sisson, T. H. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00555.2004 · Cited by 76
Mutant mice with small amounts of BubR1 display accelerated age-related gliosis
Hartman, T. K., Wengenack, T. M., Poduslo, J. F., & van Deursen, J. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.012 · Cited by 54
Characterization Of IGFBP-3, PAI-1 and SPARC mRNA expression in senescent fibroblasts
Wang, S. (1996) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(96)01814-3 · Cited by 41
Mechanisms stimulating protein degradation to cause muscle atrophy
Price, S. R., & Mitch, W. E. (1998) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-199801000-00013 · Cited by 29
Ohlson, N., Bergh, A. R. J., Persson, M. L., & Wikström, P. (2006) · The Prostate · doi:10.1002/pros.20368 · Cited by 27
Hengstschläger, M., Pusch, O., Hengstschläger-Ottnad, E., Ambros, P. F., BERNASCHEK, G., & Wawra, E. (1996) · DNA and Cell Biology · doi:10.1089/dna.1996.15.41 · Cited by 18
Cited by
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Self-citationDNA methylation-based biomarkers and the epigenetic clock theory of ageing
Horvath, S., & Raj, K. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0004-3 · Cited by 3,095
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
“Consistent with this idea is the observation that interference with senescent cell accumulation in BubR1 progeroid mice delays several aging-associated disorders that these animals develop 4, 5 .”
Self-citationCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
Metadata
- Authors
- Baker, D. J., Perez-Terzic, C., Jin, F., Pitel, K. S., Niederländer, N. J., Jeganathan, K., Yamada, S., Reyes, S., Rowe, L., Hiddinga, H. J., Eberhardt, N. L., Terzic, A., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2008-05-30
- Volume
- 10
- Issue
- 7
- Pages
- 825-836
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC2594014
- OpenAlex
- W1982763980
- Cited by
- 408
- References
- 50
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 24 · 2023: 20 · 2022: 26 · 2021: 32 · 2020: 30 · 2019: 23 · 2018: 25 · 2017: 29 · 2016: 29 · 2015: 24 · 2014: 27 · 2013: 17 · 2012: 20
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Update notices
- erratum (2012-05-30)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Ellison Medical Foundation
- National Institutes of Health
- National Cancer Institute (R01CA096985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- p16INK4a, p19ARF, cellular senescence, aging, tumour suppressor, skeletal muscle, adipose tissue, premature aging, checkpoint kinase 2
- MeSH terms
- Adipose Tissue, Aging, Animals, Cells, Cultured, Eye, Fibroblasts, Genotype, Humans, Male, Mice, Inbred C57BL, Neoplasms, Tissue Distribution, Biomarkers, Survival Rate, Cellular Senescence, Protein Serine-Threonine Kinases, Mice, Knockout, Muscle, Skeletal, Cell Cycle Proteins, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.